about
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies f...
Read More
22.21
0.33
(1.51%)
166.4K
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for GH Research PLC is scheduled for today, for the purpose of GH Research PLC First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
GH Research PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..